If this is the level of DD (articles or drug trials)of people that are investing in EXEL then we are all Fuc**$! And also the prices are sensitive to headlines rather than the content we are also fuc*$$ again.
WTF are u talking about idiot??? It has everything to do with EXEL
" I'm talking about contract research organizations (CROs), which are essentially outsourcing companies hired by pharmaceutical and biotech companies to run pre-clinical tests and clinical trials for them. The constant expansion and contraction of clinical trials as drugs enter and leave the clinic can wreak havoc on the budgeting for companies -- especially development stage companies like Exelixis (Nasdaq: EXEL).